Detalhe da pesquisa
1.
Matrix Metalloproteinase Activity in Infections by an Encephalitic Virus, Mouse Adenovirus Type 1.
J Virol
; 91(6)2017 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28053109
2.
Immunosuppressive Myeloid Cells' Blockade in the Glioma Microenvironment Enhances the Efficacy of Immune-Stimulatory Gene Therapy.
Mol Ther
; 25(1): 232-248, 2017 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28129117
3.
Epigenetic Reprogramming of Autophagy Drives Mutant IDH1 Glioma Progression and Response to Radiation.
bioRxiv
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38559270
4.
WNT signaling in the tumor microenvironment promotes immunosuppression in murine pancreatic cancer.
J Exp Med
; 220(1)2023 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36239683
5.
Analysis of donor pancreata defines the transcriptomic signature and microenvironment of early pre-neoplastic pancreatic lesions.
bioRxiv
; 2023 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36712058
6.
Arginase 1 is a key driver of immune suppression in pancreatic cancer.
Elife
; 122023 02 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36727849
7.
H3.3-G34R Mutation-Mediated Epigenetic Reprogramming Leads to Enhanced Efficacy of Immune Stimulatory Gene Therapy in Pediatric High-Grade Gliomas.
bioRxiv
; 2023 Jun 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37398299
8.
Zinc Finger MYND-Type Containing 8 (ZMYND8) Is Epigenetically Regulated in Mutant Isocitrate Dehydrogenase 1 (IDH1) Glioma to Promote Radioresistance.
Clin Cancer Res
; 29(9): 1763-1782, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36692427
9.
Analysis of Donor Pancreata Defines the Transcriptomic Signature and Microenvironment of Early Neoplastic Lesions.
Cancer Discov
; 13(6): 1324-1345, 2023 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37021392
10.
KRT17High/CXCL8+ tumor cells display both classical and basal features and regulate myeloid infiltration in the pancreatic cancer microenvironment.
Clin Cancer Res
; 2023 Oct 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851080
11.
Using Single Cell Transcriptomics to Elucidate the Myeloid Compartment in Pancreatic Cancer.
Front Oncol
; 12: 881871, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35664793
12.
Systemic Delivery of an Adjuvant CXCR4-CXCL12 Signaling Inhibitor Encapsulated in Synthetic Protein Nanoparticles for Glioma Immunotherapy.
ACS Nano
; 16(6): 8729-8750, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35616289
13.
H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models.
J Clin Invest
; 132(22)2022 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-36125896
14.
Targeting gliomas with STAT3-silencing nanoparticles.
Mol Cell Oncol
; 8(2): 1870647, 2021 Jan 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-33855166
15.
A novel miR1983-TLR7-IFNß circuit licenses NK cells to kill glioma cells, and is under the control of galectin-1.
Oncoimmunology
; 10(1): 1939601, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34249474
16.
Genetic Alterations in Gliomas Remodel the Tumor Immune Microenvironment and Impact Immune-Mediated Therapies.
Front Oncol
; 11: 631037, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34168976
17.
Inhibition of 2-hydroxyglutarate elicits metabolic reprogramming and mutant IDH1 glioma immunity in mice.
J Clin Invest
; 131(4)2021 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-33332283
18.
An Optimized Protocol for In Vivo Analysis of Tumor Cell Division in a Sleeping Beauty-Mediated Mouse Glioma Model.
STAR Protoc
; 1(2)2020 09 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-32984853
19.
Functional assay to assess T-cell inhibitory properties of myeloid derived suppressor cells (MDSCs) isolated from the tumor microenvironment of murine glioma models.
Methods Enzymol
; 632: 215-228, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32000897
20.
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy.
Nat Commun
; 11(1): 5687, 2020 11 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33173024